Meeting
2016 Gastrointestinal Cancers Symposium
Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT.
Authors
Nitya Prabhakar Raj
Memorial Sloan Kettering Cancer Center, New York, NY
Nitya Prabhakar Raj , Tara Soumerai , Emily Valentino , Jaclyn Frances Hechtman , Michael F. Berger , Diane Lauren Reidy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 246)
DOI
10.1200/jco.2016.34.4_suppl.246
Abstract #
246
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs).
First Author: Darren Cowzer
Poster
2018 Gastrointestinal Cancers Symposium
Utility of comprehensive genomic profiling (CGP) to distinguish neoplasms pathologically diagnosed as PanNETs and PanNECs and identify potentially actionable genomic alterations (GA).
First Author: Aatur D. Singhi
Poster
2022 ASCO Annual Meeting
Genomic correlates of response to capecitabine and temozolomide (CAPTEM) in pancreatic neuroendocrine tumors.
First Author: Patrick Lee
Poster
2018 ASCO Annual Meeting
Comprehensive genomic profiling of 724 gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Author: Alberto Puccini